Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

PROTOCOL TREATMENT for Acute Lymphoblastic Leukemia Ph '(BCR / ABL) POSITIVE PATIENTS AGED> 55 YEARS

NCT01376427•PETHEMA Foundation

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Acute Lymphoblastic Leukemia Ph Positive

Interventions

Dexamethasone

Methotrexate

+1 more

Locations

Spain

Locations (1)

Hospital Germans Trias i Pujol and all Hospital Pethema

Badalona, Barcelona, Spain

Key Dates

Start Date

January 1, 2007

Primary Completion Date

December 1, 2022

Completion Date

December 1, 2022

Last Updated

June 15, 2022

Sponsors

Lead Sponsor

PETHEMA Foundation

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 15, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions